The Epilepsy Surgery Market Size was valued at USD 1.20 billion in 2023 and is expected to reach USD 2.00 billion by 2032 and grow at a CAGR of 5.87% over the forecast period 2024-2032.
Get more information on Epilepsy Surgery Market - Request Sample Report
The report examines the rising incidence and prevalence of epilepsy, driving the demand for surgical treatments across various regions. The report highlights trends in epilepsy surgery, including the adoption of advanced techniques, and looks into healthcare spending on epilepsy surgeries by region, emphasizing differences in funding and accessibility. It also addresses the availability of specialized surgical centers and experts, which is crucial for improving patient outcomes.
Drivers
Growing Prevalence of Drug-Resistant Epilepsy and the Need for Surgical Intervention
One of the major driving forces for the epilepsy surgery market is the growing prevalence of drug-resistant epilepsy, affecting about 30–40% of epilepsy patients, who fail to gain seizure control even with the optimal anti-seizure medication therapy. It is also termed medically intractable epilepsy. Patients suffering from this condition are left with fewer options for treatment, which heavily handicaps them and increases their chances of suffering sudden unexpected death from epilepsy (SUDEP). As reported by the World Health Organization, epilepsy affects about 50 million people around the world, and most of these people have a considerable chance of being treated by surgical intervention.
Technological progress has streamlined the process of the least invasive, latest investigations in surgery regarding epilepsy. Robot-assisted surgery, particularly with the ROSA robotic system, offers enhanced precision of stereoelectroencephalography (sEEG) electrode placement, which is a critical step in diagnosing and treating epilepsy. LITT, or laser interstitial thermal therapy, is a minimally invasive procedure guided by MRI that has gained popularity as an alternative to open resections, especially in mesial temporal lobe epilepsy (MTLE). Other options for neuromodulation are responsive neurostimulation (RNS) from NeuroPace and vagus nerve stimulation (VNS) therapy, offering non-respective alternatives to patients who do not make the ideal candidates for traditional surgery. Increased awareness and early diagnosis campaigns by organizations like the Epilepsy Foundation, the International League Against Epilepsy (ILAE), and the National Association of Epilepsy Centers (NAEC) have added more patients to the pool of potential surgical patients.
Restraints
Financial aid programs, surgeon training initiatives, and awareness campaigns will be crucial for expanding epilepsy surgery access worldwide.
High costs are a major obstacle, especially in LMICs, where the average cost of epilepsy surgery varies between USD 20,000 and USD 50,000, which is often more than the average annual household income. Limited accessibility to specialized centers with special epilepsy facilities also hampers its treatment availability. For example, in sub-Saharan Africa, one center in every 50 million people exists, while in high-income countries, one in every 5 million people exists. There is also a setback for untrained neurosurgeons and epileptologists. According to the report of the World Federation of Neurology, many LMICs have less than one neurologist for 100,000 people, and also, for most patients, epilepsy surgery is still an unrealistic option due to the risks involved with surgery: cognitive impairment, infections, and memory loss. Generally, studies have shown that epilepsy surgery has a success rate of 50-80%.
Opportunities
Emerging markets are playing a critical role in improving patient care, and fostering innovation in cutting-edge neurosurgical technologies.
The epilepsy surgery sector has significant growth opportunities in emerging markets, especially due to increasing investments in healthcare infrastructure across Asia-Pacific and Latin America. India has established over 20 specialized epilepsy centers to improve access to surgical interventions for drug-resistant epilepsy patients. Similarly, Brazil has launched national epilepsy surgery programs that have expanded treatment options for the underserved. The use of minimal invasiveness in surgery by adopting MRI-guided laser ablation, often referred to as LITT, is increasingly getting popular because the recovery time is minimized, complications minimized, and there is a much shorter stay at the hospital. Clinical studies found that LITT achieves more than 60 percent seizure freedom in focal epilepsy cases, making the alternative to an open surgery suitable. China, and Mexico, are some of those countries that assimilated LITT into their neurosurgical service programs, to expose more patients to such advanced processes. Furthermore, increased funding for neurological research and clinical trials has been fueling innovation in the treatment of epilepsy. NIH and international epilepsy foundations are working on advancements in robot-assisted surgery, DBS, and RNS that have improved the precision and outcomes for patients. Clinical trials have begun in Mexico and Argentina intending to expand indications for surgical intervention based on neuromodulation techniques.
Challenges
Its adoption is hindered by factors such as limited awareness, complex patient selection, and lack of access to necessary infrastructure.
The studies indicate that only 1% to 2% of the eligible patients go for surgical intervention. Almost 30% of the patients suffering from epilepsy are drug-resistant and are potential candidates for surgery. A major reason is lacking awareness among the patients and also among the doctors. Most neurologists refer the patient for surgery a bit too late or not at all because they seem to have several misconceptions about it. According to research published in Neurology, the median delay from the onset of epilepsy to surgery exceeds 20 years, which may largely reduce the potential benefits of early intervention. The other crucial challenge is the complexity of patient selection and pre-surgical evaluation that involves comprehensive testing including video EEG monitoring, high-resolution MRI, PET scans, and neuropsychological assessments. These assessments require interdisciplinary teams, consisting of epileptologists, neurosurgeons, radiologists, and neuropsychologists, which are not available in most healthcare settings, especially in LMICs. For example, a survey of epilepsy centers in sub-Saharan Africa reported that less than 10% had the infrastructure to support epilepsy surgery programs.
By Procedure Type
In 2023, the Laser Interstitial Thermal Therapy (LITT) segment dominated the Epilepsy Surgery Market, holding 48.9% of the market share. Being a minimally invasive procedure with decreased recovery time and complications when compared to standard surgery, it is preferred among both patients and healthcare givers. In LITT, the laser destroys parts of the brain tissue associated with seizures in focal drug-resistant epilepsy.
Despite its dominance, Resective Surgery is the fastest-growing segment. This method of removal of brain tissue causing seizures is effective for localized drug-resistant epilepsy and results in significant improvement. Advances in presurgical diagnostics such as advanced imaging and monitoring techniques have improved the outcomes of resective surgeries, thereby increasing the adoption and growth of this segment, especially among patients with well-defined focal epilepsy.
By End User
The Hospitals & Clinics segment dominated the epilepsy surgery market in 2023 with a market share of 65.9%. Hospitals and clinics are the common sites for most epilepsy surgeries. They provide patients with all forms of pre-surgical, surgical, and post-surgical follow-ups- for comprehensive treatment of epilepsy. All the necessary, specialized equipment can be found within hospitals, accompanied by a multi-disciplinary team that can easily handle complex epilepsy cases and even offers a large range of treatment options, which include resective surgery and deep brain stimulation.
The Specialty Centers segment is the fastest-growing within this market. Such specialty centers provide highly specialized care and treatments, including advanced technologies like responsive neurostimulation and laser interstitial thermal therapy. With the increasing demand for personalized and targeted care, specialty centers are gaining more popularity, especially for patients who require focused epilepsy treatment options. Their ability to provide dedicated epilepsy care is driving their fast-paced growth in the market.
North America was the largest market, accounting for a large share of the global share in 2023 on account of high awareness, advanced medical technologies, and well-developed healthcare infrastructure. The United States has several world-class epilepsy centers and serves as a hotbed for newer treatments such as Laser Interstitial Thermal Therapy (LITT) and responsive neurostimulation. Reimbursement policies are also quite favorable within this region.
In Europe, the market is also growing steadily, leaders in this region include Germany, France, and the UK. European countries are becoming more interested in less invasive surgeries because patients can receive more advanced diagnostic measures and surgical technology. Regional disparities in access to some forms of care and reimbursement in certain European countries, however, restrict growth a little.
The Asia-Pacific region is poised to be the growth leader in the market due to increasing healthcare investments, raising awareness, and improving accessibility to advanced medical care. Countries like China, India, and Japan are also experiencing an upsurge in people suffering from epilepsy, thus maintaining demand for surgical treatments. However, despite the challenges of limited access to specialized centers in rural areas, the infrastructure and awareness-building campaigns seem to be pushing the market growth forward.
Need any customization research on Epilepsy Surgery Market - Enquiry Now
Stryker - Neurovascular Products, Neuro Navigation Systems
Zimmer Biomet Holdings Inc. - Mazor Robotics, Robotic-Assisted Surgery Systems
Auris Health Inc. (Hansen Medical Inc.) - Auris Surgical Robotics System
Intuitive Surgical - da Vinci Surgical System
Medtronic Plc (Mazor Robotics) - Mazor X Stealth, Responsive Neurostimulation (RNS)
Cephalon Inc. - Acthar Gel
CMR Surgical - Versius Surgical Robot
Natus Medical Incorporated - EEG Monitoring Systems, Intraoperative Neuromonitoring (IONM) Systems
Livanova Plc - Vagus Nerve Stimulation (VNS) Therapy
Monteris Medical - NeuroBlate System
In July 2024, Cleveland Clinic Abu Dhabi, a part of the M42 group, achieved a significant milestone by performing the UAE's first stereoelectroencephalography (SEEG) procedure. This minimally invasive technique is designed to precisely locate the origins of difficult-to-treat focal epileptic seizures in the brain, marking a major advancement in the region's epilepsy treatment capabilities.
| Report Attributes | Details |
|---|---|
|
Market Size in 2023 |
USD 1.20 Billion |
|
Market Size by 2032 |
USD 2.00 Billion |
|
CAGR |
CAGR of 5.87% From 2024 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2020-2022 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
• By Procedure Type [Resective Surgery, Laser Interstitial Thermal Therapy (LITT)] |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
|
Company Profiles |
Stryker, Zimmer Biomet Holdings Inc., Auris Health Inc. (Hansen Medical Inc.), Intuitive Surgical, Medtronic Plc (Mazor Robotics), Cephalon Inc., CMR Surgical, Natus Medical Incorporated, Livanova Plc, and Monteris Medical. |
Ans: The Epilepsy Surgery market is anticipated to grow at a CAGR of 5.87% from 2024 to 2032.
Ans: The market is expected to reach USD 2.00 billion by 2032, increasing from USD 1.20 billion in 2023.
Ans: Advancing Epilepsy Surgery, Addressing Drug-Resistant Epilepsy Through Innovation and Awareness.
Ans: Financial aid programs, surgeon training initiatives, and awareness campaigns will be crucial for expanding epilepsy surgery access worldwide.
Ans: North America dominated the Epilepsy Surgery market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Epilepsy Surgery Trends by Region (2023)
5.3 Healthcare Spending on Epilepsy Surgery, by Region (2023)
5.4 Surgical Centers and Expert Availability, by Region
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Epilepsy Surgery Market Segmentation, by Procedure Type
Chapter Overview
7.2 Resective Surgery
7.2.1 Resective Surgery Market Trends Analysis (2020-2032)
7.2.2 Resective Surgery Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Laser Interstitial Thermal Therapy (LITT)
7.3.1 Laser Interstitial Thermal Therapy (LITT) Market Trends Analysis (2020-2032)
7.3.2 Laser Interstitial Thermal Therapy (LITT) Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Epilepsy Surgery Market Segmentation, by End User
Chapter Overview
8.2 Hospitals & Clinics
8.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
8.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Specialty Centers
8.3.1 Specialty Centers Market Trends Analysis (2020-2032)
8.3.2 Specialty Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.2.4 North America Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.2.5.2 USA Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.2.6.2 Canada Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.6.2 France Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.5.2 China Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.5.2 India Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.5.2 Japan Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.9.2 Australia Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.2.4 Africa Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Epilepsy Surgery Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.6.4 Latin America Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Epilepsy Surgery Market Estimates and Forecasts, by Procedure Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Epilepsy Surgery Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10. Company Profiles
10.1 Stryker
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Zimmer Biomet Holdings Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Auris Health Inc. (Hansen Medical Inc.)
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Intuitive Surgical
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Medtronic Plc (Mazor Robotics)
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Cephalon Inc.
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 CMR Surgical
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Natus Medical Incorporated
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Livanova Plc
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Monteris Medical
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Procedure Type
Resective Surgery
Laser Interstitial Thermal Therapy (LITT)
By End User
Hospitals & Clinics
Specialty Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Digital Therapeutics Market size was estimated at USD 6.3 billion in 2023 and is expected to reach USD 50.2 billion by 2032 at a CAGR of 25.9% during the forecast period of 2024-2032.
The U.S. Healthcare Payer Services Market Size was valued at USD 34.29 Billion in 2023 and is witness to reach USD 65.31 Billion by 2032 and grow at a CAGR of 7.74% over the forecast period 2024-2032.
The Allergy Diagnostics Market size was valued at USD 4.91 billion in 2023 and is expected to reach USD 13.68 billion by 2032 at a CAGR of 12.06% during the forecast period of 2024-2032.
Heating Pad Market size was valued at USD 51.78 billion in 2023 and is expected to grow to USD 81.52 billion by 2032 and grow at a CAGR of 5.19% from 2024-2032.
The Neurorehabilitation Market was valued at USD 1.95 billion in 2023 and expected to reach USD 6.18 billion by 2032, at a CAGR of 13.68%.
The Online Pharmacy Market size was valued at USD 112.88 billion in 2023 and is estimated to reach USD 399.10 Billion by 2031 and grow at a CAGR of 17.1% over the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
